332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster III

Heavy Menstrual Bleeding in Adolescents on Direct Oral Anticoagulants

Natural History of Isolated Splanchnic Vein Thrombosis in Cancer Patients

All-Cause Mortality after Major Gastrointestinal Bleeding Among Patients Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis

Inflammation Sub-Group Analysis in Pediatric HA-VTE Cases: A Report from the Children’s Hospital Acquired Thrombosis Registry (CHAT) Registry

Management and Evolution after VTE Recurrence and/or Bleeding in Cancer Patients Receiving Anticoagulant Therapy for VTE: A Nationwide Cohort Study in

Inherited Thrombophilia Gene Mutations and Risk of Venous Thromboembolism in Cancer: A Systematic Review and Meta-Analysis

Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis

Apixaban Vs Vitamin K Antagonist As Anticoagulant Therapy in Patients with End-Stage Kidney Disease on Hemodialysis and with Atrial Fibrillation

Efficacy and Safety of Rivaroxaban As Thromboprophylaxis in Newly Diagnosed Multiple Myeloma Patients Receiving Immunomodulatory and Dexamethasone Bas

Utilization of International Normalized Ratio-Derived Formula to Predict Plasma Rivaroxaban Level – Validation Study and Real-World Experience

Venous Thromboembolism in Hematopoietic Stem Cell Transplantation

Identifying Novel Coagulation Biomarkers for Thrombosis in Patients with Lymphoma

Diagnosis, Management and Outcomes in Children with Paget Schroetter Syndrome: A Retrospective Cohort Study

Treatment Complications of Venous Thromboembolism in Patients with Central Nervous System Tumors

Thrombosis in Young Women on Ocps Likely Is Caused By an Unmasking Effect of Estrogens on Underlying Thrombophilias